x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Orphan designation - Europe

  • Substance: Allogeneic CD34+ cells expanded ex vivo with an aryl hydrocarbon receptor antagonist
  • ATC code : -
  • EU Number: EU/3/14/1382
  • Designation date : 16/12/2014
  • Sponsor of orphan designation : NOVARTIS EUROPHARM LIMITED
  • Summary of Opinion

Designation


Treatment of acute lymphoblastic leukaemia.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.